Abbott's trading volume on March 16 was $813 million, ranking 122nd among US stocks that day.

K-LinePoet · 2026-03-24T00:17:36+00:00

On March 16, 2026, Abbott (ABT) had a trading volume of $813 million, a decrease of 14.93% compared to the previous day. The stock increased by 1.78% to $109.95, but it has declined over the past five days and throughout March, with a year-to-date decrease of 12.24%. Abbott was founded in 1900 and focuses on healthcare products.

K-LinePoet

2026-03-24 00:17:36

Abstract generation in progress

On March 16, 2026, healthcare equipment company Abbott (ABT) had a trading volume of $813 million, ranking 122nd among U.S. stocks for the day. The trading volume decreased by 14.93% compared to yesterday, with a total of 7.4383 million shares traded.

Abbott (ABT) rose 1.78% on March 16, 2026, closing at $109.95. The stock has fallen 2.40% over the past 5 trading days, down 5.50% for the entire month of March, and has declined 12.24% since the beginning of the year. Over the past 52 weeks, it has decreased by 13.23%.

*If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to now (this also applies to companies listed for less than 1 month or fewer than 5 trading days).

Abbott (ABT)	Trading Volume / USD	Change from Yesterday	Volume
March 16, 2026	$813 million	-14.93%	7.4383 million
March 13, 2026	$956 million	-19.02%	8.8289 million
March 12, 2026	$1.181 billion	+33.83%	10.8398 million
March 11, 2026	$882 million	-8.82%	8.0032 million
March 10, 2026	$968 million	-36.25%	8.7461 million

Abbott is a company based in Illinois, founded in 1900. Its main business involves discovering, developing, manufacturing, and selling a wide range of healthcare products. The company has four reportable segments: pharmaceuticals, diagnostic products, nutritional products, and medical devices.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.